In calling for more clinical testing of vaccines in younger people and those who face a low risk of severe disease from Covid ...

Disclaimer: The ALLELE study was sponsored by ATARA Biotherapeutics. Prescribing information and adverse events reporting for Ebvallo (tabelecleucel) for UK HCPs can be found here. For those outside ...

It’s a tale of two U.S. Food and Drug Administration decisions – one negative and the other positive – involving two different local immunotherapy ...

The FDA notice also granted a date for the company to meet with agency officials to go over the path to resubmitting Ebvallo for consideration. Atara stock jumped 6% on the news. ImmunityBio ...

Atara's planned transition of substantially all remaining activities relating to EBVALLO to Pierre Fabre and the timing thereof; (4) Atara's planned cost reduction strategies; and (5) the ...

to discuss the plan to address the issues raised by the FDA in the CRL and the path forward for resubmission of the EBVALLO™ BLA.

Tabelecleucel (tab-cel ® or Ebvallo™) for Post-Transplant Lymphoproliferative Disease (PTLD) The FDA has lifted the clinical holds on EBVALLO™ studies. Atara plans to resume enrollment in the ...

Tabelecleucel (tab-cel ® or Ebvallo™) for Post-Transplant Lymphoproliferative Disease (PTLD) The FDA has lifted the clinical holds on EBVALLO™ studies. Atara plans to resume enrollment in the Phase 3 ...